Article Details
Retrieved on: 2021-08-04 19:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Phase 1 clinical trial of FT538 in combination with the CD38-targeted monoclonal antibody daratumumab in patients with relapsed / refractory AML, ...
Article found on: www.globenewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here